Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study

por Hokstad, Ingrid, Deyab, Gia, Wang Fagerland, Morten, Lyberg, Torstein, Hjeltnes, Gunnbjørg, Førre, Øystein, Agewall, Stefan, Mollnes, Tom Eirik, Hollan, Ivana
Publicado 2019

Effects of Antirheumatic Treatment on Cell Cholesterol Efflux and Loading Capacity of Serum Lipoproteins in Spondylarthropathies

por Hokstad, Ingrid, Greco, Daniela, Deyab, Gia, Fagerland, Morten Wang, Agewall, Stefan, Hjeltnes, Gunnbjørg, Zimetti, Francesca, Bernini, Franco, Ronda, Nicoletta, Hollan, Ivana
Publicado 2022

Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis

por Deyab, Gia, Hokstad, Ingrid, Whist, Jon Elling, Smastuen, Milada Cvancarova, Agewall, Stefan, Lyberg, Torstein, Ronda, Nicoletta, Mikkelsen, Knut, Hjeltnes, Gunnbjorg, Hollan, Ivana
Publicado 2017

Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis

por Deyab, Gia, Hokstad, Ingrid, Whist, Jon Elling, Småstuen, Milada Cvancarova, Agewall, Stefan, Lyberg, Torstein, Bottazzi, Barbara, Meroni, Pier Luigi, Leone, Roberto, Hjeltnes, Gunnbjorg, Hollan, Ivana
Publicado 2017

Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis

por Nguyen, Thao H. P., Hokstad, Ingrid, Fagerland, Morten Wang, Mollnes, Tom Eirik, Hollan, Ivana, Feinberg, Mark W., Hjeltnes, Gunnbjørg, Eilertsen, Gro Ø., Mikkelsen, Knut, Agewall, Stefan
Publicado 2022